NGM Biopharmaceuticals, Inc. Soared

Thu, Oct 20, 2022 at 07:09 PM

NGM Biopharmaceuticals, Inc. (NGM:NASDAQ) rocketted at $4.49, representing a gain of 21.7%. The stock got featured on our News Catalysts scanner on Mon, Oct 17, 2022 at 03:14 PM in the 'BIOTECH' category. From Thu, Oct 06, 2022, the stock recorded 40.00% Up Days and 45.45% Green Days

About NGM Biopharmaceuticals, Inc. (NGM:NASDAQ)

NGM Biopharmaceuticals Inc is a clinical-stage bio-pharmaceutical company. It is engaged in developing novel therapeutics based on scientific understanding of key biological pathways for the treatment of cardio-metabolic, liver, oncologic and ophthalmic diseases.

Top 10 Gainers:

NextPlay Technologies Inc. (NXTP:NASDAQ), 107.31%
Quanergy Systems Inc. (QNGY:NYSE), 51.2%
Cabaletta Bio, Inc. (CABA:NASDAQ), 50.77%
Save Foods Inc. (SVFD:NASDAQ), 31.33%
Pineapple Holdings Inc Com (PEGY:NASDAQ), 29.74%
Creatd Inc. (CRTD:NASDAQ), 28.97%
Katapult Holdings Inc. (KPLT:NASDAQ), 24.31%
VolitionRx Limited (VNRX:NYSEMKT), 22.76%
NGM Biopharmaceuticals, Inc. (NGM:NASDAQ), 21.68%
Skillz Inc. Class A (SKLZ:NYSE), 21.47%